Targeting specific cell types with silencing RNA

New England Journal of Medicine

Volumn 353, Issue 13, 2005, Pages 1410-1411

  Williams, Bryan R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CELL SURFACE RECEPTOR; DOUBLE STRANDED RNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOGLOBULIN F(AB) FRAGMENT; OLIGONUCLEOTIDE; PROTAMINE; RNA; SMALL INTERFERING RNA;

ANGIOGENESIS; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CULTURE; CELL CYCLE; CELL TYPE; DENDRITIC CELL; DNA BINDING; DRUG TARGETING; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SEQUENCE; GENE SILENCING; GENE TARGETING; GENETIC ENGINEERING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFLAMMATION; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; TARGET CELL; TARGET ORGAN; TUMOR;

ANIMALS; DRUG DELIVERY SYSTEMS; GENE SILENCING; HIV ENVELOPE PROTEIN GP160; HIV-1; HUMANS; MELANOMA, EXPERIMENTAL; MICE; PROTAMINES; RECEPTORS, CELL SURFACE; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING;

EID: 25444494406     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcibr052492     Document Type: Article

References (1)

1. Song E, Zhu P, Lee SK, et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 2005;23:709-17.